08/13/12 Last month, the world lost a journalist, essayist, playwright, screenwriter, novelist, producer, director, and blogger; and one astonishing woman – the beloved Nora Ephron. At the age of 71, Ms. Ephron died of pneumonia brought on by acute myeloid leukemia; a tragic death that deeply touched us at Kanzius Cancer Research Foundation. Despite battling leukemia since 2006, her death was not directly caused by the disease, but rather a direct result of side effects caused by cancer treatments. The news of Ephron’s passing comes a mere month after we learned about Robin Roberts’ most recent diagnosis of MDS – another side effect of cancer and its subpar treatments.
When will this unnerving cycle of cancer, chemo treatments, remission, and finally a “side-effect” diagnosis be stopped? It is unacceptable that in this day and age, cancer patients have to continually live with the possibility of being diagnosed with a separate disease because of their cancer treatment. Kanzius Cancer Research Foundation has been working since 2008 to stop this growing list of people. It is not only the list of famous celebrities that Kanzius is trying to help, but every single past, present, and future cancer patient. No one should have to live with the possibility of dying from not only cancer, but also the hundreds of diseases that can take life stemming from the disease.
It still surprises and disheartens me to hear that so many people do not believe that a better way is probable. A better way is the only way forward – a better way is the only logical evolution of cancer treatment. Kanzius Cancer Research Foundation strongly believes this, and this is why we continue working despite industry naysayers. Every day we hear stories from people who believe in and encourage our mission. These believers make it possible to move forward with their kind words, inspiring stories, and contributions. This Foundation is unlike any other cancer foundation or organization in existence. We are not driven by the possibilities of economic development. We are not looking for a claim to fame. We simply want to bring John Kanzius’ dream and device to the people. We want a better way.
As with anything worth its salt, it takes a lot of hard work, commitment, will, and time to transform an idea into reality. The Kanzius Noninvasive Radiowave Cancer Treatment is no different. We are finally at the point of conducting tests on large, non-human laboratory subjects, the final stage before presenting to the FDA for human trials. This is not the time for doubt. This is the moment where we all need to keep believing. We are considerably closer than we were last year at this time. Our goal is to simply take this treatment to human trials. We look forward to the day when we can finally close the doors to the Foundation because it means we have reached this goal. There is no private agenda.
Kanzius Cancer Research Foundation, unlike most other “cancer specific” foundations, is “treatment specific.” This past year, over 85 cents of every dollar was expended for our mission. Annually, each Director and staff member signs a “Code of Ethics and Conflict of Interest Statement.” We cannot allow anything to stand in the way.
We realize our days are numbered as we move toward the finish line. Your continued generous support will make a financial impact in validating this treatment for generations to come. Please keep believing!
MARK A. NEIDIG SR. is executive director of the Kanzius Cancer Research Foundation (MNeidig@Kanzius.org).